Abstract:Enhanced osteoclastogenesis and osteoclast activity contribute to the development of osteoporosis, which is characterized by increased bone resorption and inadequate bone formation. As novel antiosteoporotic therapeutics are needed, understanding the genetic regulation of human osteoclastogenesis could help identify potential treatment targets. This study aimed to provide an overview of transcriptional reprogramming during human osteoclast differentiation. Osteoclasts were differentiated from CD14 + monocytes from eight female donors. RNA sequencing during differentiation revealed 8 980 differentially expressed genes grouped into eight temporal patterns conserved across donors. These patterns revealed distinct molecular functions associated with postmenopausal osteoporosis susceptibility genes based on RNA from iliac crest biopsies and bone mineral density SNPs. Network analyses revealed mutual dependencies between temporal expression patterns and provided insight into subtype-specific transcriptional networks. The donor-specific expression patterns revealed genes at the monocyte stage, such as filamin B ( FLNB ) and oxidized low-density lipoprotein receptor 1 ( OLR1 , encoding LOX-1), that are predictive of the resorptive activity of mature osteoclasts. The expression of differentially expressed G-protein coupled receptors was strong during osteoclast differentiation, and these receptors are associated with bone mineral density SNPs, suggesting that they play a pivotal role in osteoclast differentiation and activity. The regulatory effects of three differentially expressed G-protein coupled receptors were exemplified by in vitro pharmacological modulation of complement 5 A receptor 1 ( C5AR1 ), somatostatin receptor 2 ( SSTR2 ), and free fatty acid receptor 4 ( FFAR4 /GPR120). Activating C5AR1 enhanced osteoclast formation, while activating SSTR2 decreased the resorptive activity of mature osteoclasts, and activating FFAR4 decreased both the number and resorptive activity of mature osteoclasts. In conclusion, we report the occurrence of transcriptional reprogramming during human osteoclast differentiation and identified SSTR2 and FFAR4 as antiresorptive G-protein coupled receptors and FLNB and LOX-1 as potential molecular markers of osteoclast activity. These data can help future investigations identify molecular regulators of osteoclast differentiation and activity and provide the basis for novel antiosteoporotic targets.

Galectin-8 modulates human osteoclast activity partly through isoform-specific interactions

Gα13 Negatively Controls Osteoclastogenesis Through Inhibition of the Akt-GSK3β-NFATc1 Signalling Pathway

Reduced form of Galectin-1 Suppresses Osteoclastic Differentiation of Human Peripheral Blood Mononuclear Cells and Murine RAW264 Cells In Vitro

Isoform-specific regulation of osteogenic factors by polypeptide N-Acetylgalactosaminyltransferases 1 and 4

Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity

Galectin-3 Contributes to the Inhibitory Effect of lα,25-(OH)2D3 on Osteoclastogenesis

Osteoclast activity modulates B-cell development in the bone marrow

Ubiquitin-like protein MNSFβ noncovalently binds to molecular chaperone HSPA8 and regulates osteoclastogenesis

Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt Activity

Correlating Rank Ligand/Rank Binding Kinetics with Osteoclast Formation and Function

G-protein Gα13 functions as a cytoskeletal and mitochondrial regulator to restrain osteoclast function

Mutational Tuning of Galectin-3 Specificity and Biological Function

HBP/O-GlcNAcylation Metabolic Axis Regulates Bone Resorption Outcome

Linker remodels human Galectin-8 structure and regulates its hemagglutination and pro-apoptotic activity

Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption

Galectin-8 Alters Immune Microenvironment and Promotes Tumor Progression.

Isoform-specific O-glycosylation of osteopontin and bone sialoprotein by polypeptide N-acetylgalactosaminyltransferase-1

Study on pro-inflammatory effect and mechanism of galectin-9 (LGALS9) in osteoarthritis: Exacerbating inflammatory response by activating JNK and ERK1/2 pathways

Potential involvement of the interaction between insulin‐like growth factor binding protein (IGFBP)‐6 and LIM mineralization protein (LMP)‐1 in regulating osteoblast differentiation

Proteasome inhibition suppress microgravity elevated RANK signaling during osteoclast differentiation

The diverse dependence of galectin-1 and -8 on multivalency for the modulation of FGFR1 endocytosis